Accidental overdoses from 'copies' of the weight-loss drug sold commercially as Ozempic and Wegovy are on a steep rise in the US. So much so, the Food and Drug Administration (FDA) just had to ...

With oral semaglutide, the number of people discontinuing treatment due to adverse effects rose steadily according to dose from 3 mg to 25 mg, and then began decreasing at 50 mg.

In this small case series, semaglutide after the diagnosis of type 1 diabetes led to elimination of prandial insulin in all patients and basal insulin in most, along with improved glycemic control.

Tirzepatide and semaglutide are type 2 diabetes drugs often used for weight loss. While tirzepatide may potentially be more effective, it's too early to know that based on current research.

The researchers found that after 64 weeks, participants had a mean weight loss of −16.7%, with a mean semaglutide dose of 1.08mg/week. Weight loss of at least 5% and 10% was achieved by 98% and ...

SAN ANTONIO — Oral semaglutide 25 mg appears to be just as effective in promoting weight loss and other beneficial outcomes as are the investigational 50-mg oral dose and the injectable 2.4-mg ...

The average maximum dose of semaglutide was 0.77 mg, and all participants with a reported weight at week 64 lost over 5% of their body weight, and 85.3% lost over 10% of their baseline body weight.

Semaglutide is an injectable drug formulated for the treatment of type 2 diabetes, but it’s since become increasingly popular as a weight loss treatment.

Some people who take Ozempic or Wegovy (semaglutide) are using a method called “counting clicks” or microdosing to get a little more or less medication in each shot than the standard amount ...

SAN ANTONIO — Once-daily oral semaglutide conferred more weight loss vs. placebo plus lifestyle intervention and was similar vs. larger oral GLP-1 receptor agonist doses and weekly injectables ...